Chemomab Therapeutics Ltd. (CMMB) Operating cash flow 2018–2025
Chemomab Therapeutics Ltd. (CMMB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$11.1MFY2025 · since FY2018: -$14.2M → -$11.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.1M | +27.7% |
| FY2024 | -$15.4M | +34.8% |
| FY2023 | -$23.6M | -15.9% |
| FY2022 | -$20.4M | -64.6% |
| FY2021 | -$12.4M | -136.1% |
| FY2020 | -$5.2M | +68.1% |
| FY2019 | -$16.5M | -15.7% |
| FY2018 | -$14.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice